Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Science and Technology Meeting of the Faculty of Pharmaceutical Sciences, University of São Paulo. Unidade: FCF
Subjects: MODELAGEM MOLECULAR, DOENÇA DE ALZHEIMER
ABNT
FERNANDES, Thais Batista et al. Synthesis, molecular modeling and evaluation of novel sulfonylhydrazones as acethylcholinesterase inhibitors for alzheimer’s disease tratment. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 12 nov. 2024. , 2017APA
Fernandes, T. B., Cunha, M. R., Sakata, R. P., Cândido, T. M., Baby, A. R., Barbosa, E. G., et al. (2017). Synthesis, molecular modeling and evaluation of novel sulfonylhydrazones as acethylcholinesterase inhibitors for alzheimer’s disease tratment. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.NLM
Fernandes TB, Cunha MR, Sakata RP, Cândido TM, Baby AR, Barbosa EG, Almeida WP, Parise Filho R. Synthesis, molecular modeling and evaluation of novel sulfonylhydrazones as acethylcholinesterase inhibitors for alzheimer’s disease tratment. Brazilian Journal of Pharmaceutical Sciences. 2017 ; 53 54 res. FCF103.[citado 2024 nov. 12 ]Vancouver
Fernandes TB, Cunha MR, Sakata RP, Cândido TM, Baby AR, Barbosa EG, Almeida WP, Parise Filho R. Synthesis, molecular modeling and evaluation of novel sulfonylhydrazones as acethylcholinesterase inhibitors for alzheimer’s disease tratment. Brazilian Journal of Pharmaceutical Sciences. 2017 ; 53 54 res. FCF103.[citado 2024 nov. 12 ]